Skip to content
To the full analysis

Novocure stock: balance sheet and debt

NVCR
$11.72Closing price of 12 Nov 2026MEQIRI Score 29 out of 100

Novocure has a debt to equity ratio of 0.85.

Daily figure as of 13 Nov 2026

Debt / Equity
0.85
Interest coverage
no data
Current ratio
2.9
Cash & equivalents
$457.52M
Total assets
$804.33M
Equity ratio
42.3%
Goodwill
not reported separately
Net debt
−$167.52M
More cash than debt

Total assets and equity ratio

How large the balance sheet of Novocure Ltd is, how much of it is equity and how much is goodwill from acquisitions.

Equity ratio

Figures as a table
YearTotal assetsGoodwill and intangible assetsof which goodwillEquity ratioNet debt
2013$188.91Mnot reported separatelynot reported separately90.9%−$175.55M
2014$117.88Mnot reported separatelynot reported separately83.0%−$102.29M
2015$307.34Mnot reported separatelynot reported separately81.6%−$246.33M
2016$282.08Mnot reported separatelynot reported separately50.5%−$123.4M
2017$265.3Mnot reported separatelynot reported separately42.8%−$85.97M
2018$339.79Mnot reported separatelynot reported separately33.0%−$96.61M
2019$479.45Mnot reported separatelynot reported separately45.4%−$159.99M
2020$1.05Bnot reported separatelynot reported separately45.3%−$403.39M
2021$1.14Bnot reported separatelynot reported separately36.0%−$356.61M
2022$1.19Bnot reported separatelynot reported separately37.0%−$385.15M
2023$1.15Bnot reported separatelynot reported separately31.6%−$314.37M
2024$1.24Bnot reported separatelynot reported separately29.0%−$276.52M
2025$804.33Mnot reported separatelynot reported separately42.3%−$167.52M

The equity ratio divides total equity, including non-controlling interests, by total assets. Net debt is debt minus cash and short-term investments; a negative figure means cash exceeds debt.

Equity and debt

What the company owns and owes

  • Cash & equivalents
  • Equity
  • Debt
Figures as a table
YearCash & equivalentsEquityDebtDebt / Equity
2013$175.89M$171.78M$346K0
2014$102.61M$97.88M$321K0
2015$269.42M$250.82M$23.1M0.09
2016$219.63M$142.35M$96.23M0.68
2017$183.31M$113.56M$97.34M0.86
2018$245.88M$112.26M$149.27M1.33
2019$328.19M$217.79M$168.2M0.77
2020$854.08M$476.53M$450.68M0.95
2021$938.51M$410.49M$581.9M1.42
2022$969.43M$441.17M$584.27M1.32
2023$910.62M$362.5M$596.24M1.64
2024$959.87M$360.18M$683.35M1.9
2025$457.52M$340.47M$290M0.85

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Weak, published since 7 Nov 2026 (in the score history since 31 Jul 2021)
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy